eCite Digital Repository
Change in cardiovascular health and incident type 2 diabetes and impaired fasting glucose: the Whitehall II study
Climie, RE and van Sloten, TT and Perier, M-C and Tafflet, M and Fayosse, A and Dugravot, A and Singh-Manoux, A and Empana, J-P, Change in cardiovascular health and incident type 2 diabetes and impaired fasting glucose: the Whitehall II study, Diabetes Care, 42, (10) pp. 1981-1987. ISSN 0149-5992 (2019) [Refereed Article]
Copyright 2019 by the American Diabetes Association
Research Design and Methods: Within the Whitehall II study, CVH was examined every 5 years from 1991/93 until 2015/16. Subjects with 0-2, 3-4, and 5-6 ideal metrics of CVH from the American Heart Association were categorized as having low, moderate, or high CVH, respectively.
Results: There were 6,234 participants (mean age 49.8 ± 6.0 years, 70% male) without prior cardiovascular disease and T2D, including 5,015 who were additionally free from IFG at baseline. Over a median follow-up of 24.8 (interquartile range 24.0-25.2) years, 895 and 1,703 incident cases of T2D and IFG occurred, respectively. Change in CVH between 1991/93 and 2002/04 was calculated among 4,464 participants free from CVD and T2D and among 2,795 participants additionally free from IFG. In multivariate analysis, compared with those with stable low CVH, risk of T2D was lower in those with initially high CVH (hazard ratio [HR] 0.21; 95% CI 0.09, 0.51), those who had persistently moderate CVH or changed from moderate to high CVH (moderate-moderate/high; HR 0.53; 95% CI 0.41, 0.69), low-moderate/high (HR 0.62; 95% CI 0.45, 0.86), and moderate-low (HR 0.74; 95% CI 0.56, 0.98). Results were similar for IFG, but the effect sizes were smaller.
Conclusions: Compared with stable low CVH, other patterns of change in CVH were associated with lower risk of T2D and IFG.
|Item Type:||Refereed Article|
|Research Division:||Biomedical and Clinical Sciences|
|Research Group:||Cardiovascular medicine and haematology|
|Research Field:||Cardiology (incl. cardiovascular diseases)|
|Objective Group:||Clinical health|
|Objective Field:||Clinical health not elsewhere classified|
|UTAS Author:||Climie, RE (Dr Rachel Climie)|
|Web of Science® Times Cited:||12|
|Deposited By:||Menzies Institute for Medical Research|
Repository Staff Only: item control page